Menu
Back to Journals » Clinical Ophthalmology » Volume 8
A case of conjunctival mucoepidermoid carcinoma in Australia
Authors Moloney T, Trinh T, Farrah J
Received 25 September 2013
Accepted for publication 5 November 2013
Published 6 December 2013 Volume 2014:8 Pages 11—14
DOI https://doi.org/10.2147/OPTH.S54973
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 4
Thomas P Moloney,1 Tanya Trinh,2 Jonathon J Farrah1,2
1Department of Ophthalmology, The Royal Brisbane and Women's Hospital, Herston, QLD, Australia; 2Department of Ophthalmology, Mater Misericordiae Hospital, South Brisbane, QLD, Australia
Abstract: Conjunctival mucoepidermoid carcinoma is a very rare but highly aggressive conjunctival neoplasm with 42 previously reported cases. We report the case of a 56-year-old male with a left ocular surface squamous neoplasm, which was subsequently treated with excision and autoconjunctival graft. Histopathology of the operative specimen reported a low-grade conjunctival mucoepidermoid carcinoma, and the patient was then treated with an adjunctive course of mitomycin C. On review 10 months after lesion excision, there was no recurrence, and the patient was otherwise well. Due to its rare incidence, difficult clinical diagnosis, and accompanying poor prognosis, conjunctival mucoepidermoid carcinoma should always be considered in the differential diagnosis of conjunctival neoplasms, and full histopathologic examination, including mucin-staining techniques, of all suspicious conjunctival biopsies should occur.
Keywords: conjunctiva, neoplasm, pterygium, mitomycin C
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.